Viagra could cut the risk of Alzheimer’s disease by 60 per cent, study finds

• Study looked at 27,000 over-65s and found it lowered men’s risk by 62 per cent
• The research was undertaken by Mount Sinai Medical Centre in New York

Viagra cut could the risk of Alzheimer’s disease by 60 per cent, a study has found.

Researchers say that the little blue pill blocks an enzyme that has been found in the brain of those who suffer from the disease in large masses.

Viagra also helps boost the blood supply, meaning that it has the potential to treat Dementia, as it improves brain health.

The study – which looked at more than 27,000 over-65s – found that the risk was 62 per cent lower for men and 47 per cent lower for women if they took the pills. 

The research compared the results of those who had been given Viagra and those who had not taken the drug. The research was undertaken by Mount Sinai Medical Centre in New York.

Author Xingyue Huo told The Sun: ‘We found sildenafil was significantly associated with a 60 per cent lower risk of developing Alzheimer’s disease.’

Currently it is estimated that 900,000 people in the UK have Dementia, according to the Alzheimer’s Society and they also estimate that one in three people will be impacted by the disease in the future.

Recently MailOnline reported that a 32-year-old man went blind in one eye after he took Viagra. 

The man from Iran, took a bumper dose of sildenafil, the main ingredient in the little blue pill and lost sight in his right eye almost immediately afterwards. 

Despite efforts to restore his vision, the damage was too extensive and he has now lost all vision in that eye. 

Sildenafil combats impotence by boosting blood flow to the penis through relaxing the blood vessels. 

However, it is thought this effect could, in some circumstances, inadvertently harm other sensitive vessels in the body, such as those in the eyes.